Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$0.25 CAD
Change Today 0.00 / 0.00%
Volume 38.7K
AEZ On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 12:53 PM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul Blake M.D.

Former Chief Medical Officer and Senior Vice President, Aeterna Zentaris Inc.
AgeTotal Calculated CompensationThis person is connected to 24 board members in 2 different organizations across 6 different industries.

See Board Relationships
67177,000 GBP
As of Fiscal Year 2013

Background*

Dr. Paul Blake, M.D. served as Clinical Development Advisor of Protez Pharmaceuticals Inc. Dr. Blake has been Chief Development Officer of Oxford BioMedica PLC since September 1, 2014. He served as Senior Vice President and Chief Medical Officer of Aeterna Zentaris Inc. since August 5, 2007 until March 13, 2014. Dr. Blake served as Senior Vice President, Clinical Research and Development for Avigenics Inc. from January 2007 to July 2007. He has over 30 years international ...

Read Full Background

Corporate Headquarters*

1405 du Parc-Technologique Boulevard
Quebec City, Quebec G1P 4P5

Canada

Phone: 418-652-8525
Fax: 418-948-9191

Board Members Memberships*

Director
2010-Present
Chief Development Officer, Executive Director, Chairman of Remuneration Committee and Member of Nomination Committee

Education*

Unknown/Other Education
University Of London
BS
University Of London
MD
University Of London
Bachelor's Degree
Royal Free and University College Medical School

Other Affiliations*

Annual Compensation*

Salary72,000 GBP
Bonus68,000 GBP
Total Annual Compensation140,000 GBP

Stock Options*

All Other Compensation11,000 GBP
Unexercisable Options2,109,375
Total Number of Options2,109,375

Total Compensation*

Total Annual Cash Compensation177,000 GBP
Total Short Term Compensation140,000 GBP
Other Long Term Compensation11,000 GBP
Total Calculated Compensation177,000 GBP
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AEZ:CN C$0.25 CAD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Sijmen de Vries M.D., MBAChief Executive Officer and Member of Management Board
Pharming Group NV
€624.0K
Clive A. Meanwell M.D., Ph.D.Chairman and Chief Executive Officer
The Medicines Company
$874.6K
Cameron Geoffrey McDonough M.D.Chief Executive Officer and President
Swedish Orphan Biovitrum AB
kr5.4M
Edwin Moses Ph.D.Chief Executive Officer, Director and Member of Research & Development Committee
Ablynx NV
--
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AETERNA ZENTARIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.